HER2 POSITIVE BREAST CANCER

This adverse event was reported 375 times

These drugs are most commonly taken by patients reporting HER2 POSITIVE BREAST CANCER:

# Drug Count
0 TRASTUZUMAB 234
1 PERTUZUMAB 122
2 PACLITAXEL 72
3 PACLITAXEL (AIBUMIN-BOUND) 70
4 DOCETAXEL 62
5 DOCETAXEL ANHYDROUS 62
6 CAPECITABINE 54
7 CYCLOPHOSPHAMIDE 54
8 CYCLOPHOSPHAMIDE FOR INJECTION 54
9 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 54
See all common drugs associated with HER2 POSITIVE BREAST CANCER

HER2 POSITIVE BREAST CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IMLUNESTRANT 1 0.0109
1 NERATINIB 11 0.0047
2 PERTUZUMAB 122 0.0044
3 TRASTUZUMAB-DKST 1 0.0036
4 TRASTUZUMAB 234 0.0034
5 ADO-TRASTUZUMAB EMTANSINE 28 0.0033
6 FLURANDRENOLIDE 1 0.0030
7 PRUCALOPRIDE SUCCINATE 1 0.0029
8 TRASTUZUMAB-ANNS 4 0.0026
9 FINGOLIMOD HYDROCHLORIDE 10 0.0020
See all drugs enriched for association with HER2 POSITIVE BREAST CANCER